COMPASS Pathways plc (CMPS)
COMPASS Pathways (CMPS) sees significant social media buzz around its psychedelic treatments, with recent posts highlighting market comparisons and upcoming clinical trial data. Analysts and investors are closely watching its progress in treating conditions like TRD.
About COMPASS Pathways plc
COMPASS Pathways plc is a biotechnology company focused on developing psychedelic medicine for mental health treatment.
COMPASS Pathways plc uses the ticker $CMPS for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- COMPASS Pathways plc (CMPS) mentions hit [---] which is 108% higher than it's daily average.
- COMPASS Pathways plc (CMPS) social dominance is up 136.9% from the previous month.
- COMPASS Pathways plc (CMPS) Galaxy Score™ is up 84.21% from the previous month.
- COMPASS Pathways plc (CMPS) sentiment is up 65.22% from the previous week.
- COMPASS Pathways plc (CMPS) engagements is up 51.55% from the previous week.
- COMPASS Pathways plc (CMPS) posts created is up 204.55% from the previous week.
Price: $5.80
Price 24-Hour Time-Series Raw Data
The price action for CMPS shows a 1-year high, with recent movements influenced by positive analyst ratings and significant whale buying activity noted in social posts, pushing it to a 52-week and all-time high.
24-Hour: -1.36% 7-Day: -7.48% 30-Day: -20.95%
1-Year High: $7.80 on 2026-01-07
1-Year Low: $2.40 on 2025-06-23
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
COMPASS Pathways plc (CMPS) is currently AltRank #594 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [----]
1-Year High: [-----] on 2026-01-28
1-Year Low: [---] on 2026-01-24
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +18
[--] Month: [--] +32
[--] Months: [--] +27
[--] Year: [--] +25
1-Year High: [--] on 2026-02-16
1-Year Low: [--] on 2025-12-06
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] +52%
[--] Month: [-------] -37%
[--] Months: [---------] -22%
[--] Year: [---------] +69%
1-Year High: [-------] on 2025-06-23
1-Year Low: [---] on 2025-10-26
Engagements by network (24h): TikTok: [--] Reddit: [--] News: [--] YouTube: [--] X: [------]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +7.80%
[--] Month: [---] +938%
1-Year High: [---] on 2025-11-10
1-Year Low: [--] on 2025-09-14
Mentions by network (24h): TikTok: [--] Reddit: [--] News: [--] YouTube: [--] X: [---]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning COMPASS Pathways plc (CMPS) in the last [--] hours which is down 10% from [---] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +2.10%
[--] Month: [---] +639%
1-Year High: [---] on 2025-11-10
1-Year Low: [--] on 2025-05-03
The most influential creators that mention COMPASS Pathways plc in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Andre_AGTC | [--] | [-----] | [--] | [-----] |
| @seedy19tron | [--] | [------] | [--] | [-----] |
| @PersimmonTI | [--] | [------] | [--] | [-----] |
| @PsychedVantage | [--] | [-----] | [--] | [-----] |
| @Psyched_Alpha | [--] | [------] | [--] | [-----] |
| @BOSSTRADING0 | [--] | [-----] | [--] | [---] |
| @financebully | [--] | [-----] | [--] | [---] |
| @MarcJacksonLA | [--] | [-----] | [--] | [---] |
| @WhizBuckleyNFH | [--] | [-----] | [--] | [---] |
| @BowTiedBiotech | [--] | [------] | [--] | [---] |
Sentiment: 76%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 76%
Daily Average: 84%
[--] Week: 76% +30%
[--] Month: 69% -11%
[--] Months: 69% -24%
[--] Year: 69% -16%
1-Year High: 100% on 2025-03-03
1-Year Low: 32% on 2025-12-27
Most Supportive Themes:
- Top CMPS Social Posts: (75%) The top social posts for $CMPS are generating significant engagement, indicating strong community interest and discussion.
- Engagements by Network: (20%) X is the primary network for $CMPS engagements, with YouTube also contributing.
Most Critical Themes:
- Sentiment Analysis: (5%) While sentiment is currently at 67%, it is down from its daily average of 87%, suggesting a potential area of concern.
Social Dominance: 0.016%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.016%
Daily Average: 0.014%
[--] Week: 0.015% +0.0022%
[--] Month: 0.02% +0.012%
[--] Months: 0.02% +0.01%
[--] Year: 0.02% +0.007%
1-Year High: 0.08% on 2025-11-10
1-Year Low: 0.0029% on 2025-12-17
Market Dominance: 0.0006319271643505951%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0006319271643505951%
Daily Average: 0%
1-Year High: 0.00085% on 2026-01-14
1-Year Low: 0.00063% on 2026-02-16
Market Cap: $557,859,026
Market Cap 24-Hour Time-Series Raw Data
Current Value: $557,859,026
Daily Average: $642,381,458
[--] Week: $568,420,900 -8.80%
[--] Month: $557,859,026 -21%
1-Year High: $732,610,046 on 2026-01-14
1-Year Low: $548,257,321 on 2026-02-05
Top COMPASS Pathways plc Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$CMPS Compass Pathways to Announce New Clinical Data from Two Ongoing Phase [--] Trials https://www.stocktitan.net/news/CMPS/compass-pathways-to-announce-new-clinical-data-from-two-ongoing-snt48p1n8k8p.html https://www.stocktitan.net/news/CMPS/compass-pathways-to-announce-new-clinical-data-from-two-ongoing-snt48p1n8k8p.html"
X Link @MarcJacksonLA 2026-02-16T16:09Z [----] followers, [---] engagements
"Tomorrow Compass Pathways will share 6-week data from its second larger Phase [--] study of its psilocybin candidate in treatment-resistant depression. It will also share 26-week data from its first Phase [--]. Psychedelic Alpha has the full story tomorrow AM"
X Link @Psyched_Alpha 2026-02-16T15:06Z 20.9K followers, [----] engagements
"$CMPS Data release on February [--] at 6:30am webinar at 8:00am I have mainly calls and some direct shares I like when thecdata are released earlier than expected - In general is a good sign $CMPS MC 570M 6.5M diagnosed TRD pts / 3M in US TAM $6.7B+ by [----] $CMPS (COMP360) ph3 TRD data in Q1'26 NDA in H2'26 Single-dose durability vs. Spravato repeat dosing $JNJ Spravato 2019: FDA approval for TRD 2025: $1.7B revenue (blockbuster) 60% growth in q4 vs [----] $CMPS MC 570M 6.5M diagnosed TRD pts / 3M in US TAM $6.7B+ by [----] $CMPS (COMP360) ph3 TRD data in Q1'26 NDA in H2'26 Single-dose durability"
X Link @Andre_AGTC 2026-02-16T14:56Z [----] followers, [----] engagements
"@blueskymindtq @C_Angermayer @WhizBuckleyNFH $atai trd and/or $help mdd assets have the best chance of commercial success. $cmps ph3 will generate buzz but will not succeed commercially based on its current lead tpp"
X Link @financebully 2026-02-16T14:37Z [----] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing